Form 4: Agomab Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Marino Garcia, a Director of Agomab Therapeutics NV, received 57,482 shares of common stock on September 11, 2026.
Summary
- Grant/award: acquired 57,482 Stock Option (Right to Buy) on September 11, 2026; holds 57,482 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Marino Garcia — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Grant/award | Stock Option (Right to Buy) | 57,482 | — | — | 57,482 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Grant/award (57,482 shares) |
Keywords
insider transaction, Form 4, AGMB, AgomAb Therapeutics NV, neutral, Marino Garcia
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.